ulcerative colitis, inflammatory bowel disease, IBD, UC Researchers performed a systematic review of clinical trials to assess the need for a consensus on the definition of mild to moderate, active ...

BLACKSBURG, Va.--(BUSINESS WIRE)--Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases ...

SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) ...

MRM Health will be presenting at upcoming Digestive Disease Week (DDW) 2026, taking place from May 2 nd – May 5 th in Chicago, IL, USA GHENT, Belgium, April 30, 2026--(BUSINESS WIRE)--MRM Health, a ...

Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment with ...

Take this quiz to find out if UC is holding you back. Then, learn what to do next. “It’s going to vary by person [what] their ‘normal’ is,” says Jessica Philpott, MD, PhD, a gastroenterologist at ...

A new cohort study from Northern Denmark finds that mild-onset Crohn's disease (CD) has worse 10-year probability of progression to moderate-severe disease, at 53%, than that of mild-onset ulcerative ...

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...

Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) approach based on faecal calprotectin (FC) ...

MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that ...